View drug registration information details.


ItemsRegistration information
ID2208
No2208
Brand NameOMIPIN
IngredientsOMEPRAZOLE SODIUM BP EQ.TO OMEPRAZOLE 40 MG
Dosage FormPOWDER FOR SOLUTION FOR INJECTION
Primary PackagingVIAL
Storage
Shelf Life2 YEARS
Pack Size1 VIAL / BOX
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR SHORT TERM TREATMENT OF DUODENAL ULCER, GASTRIC ULCER, REFLUX OESOPHAGITIS, ZOLLINGER-ELLISON SYDROME WHEN ORAL THERAPY IS REGARDED INAPPROPRIATE OR CONTRA-INDICATED, FOR UP TO 5 DAYS
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionWHITE LYOPHILIZED MASS FILLED IN A CLEAR GLASS TUBULAR VIAL
Note
License OwnerPOUNSAB PHARMA CO.,LTD
ManufacturerBRAWN LABORATORIES LIMITED
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No04 I 4674/19
FDD Registration Date06-DEC-2022
Expiry Date05-DEC-2025

Back to drug list